This review examines the growing field of gene therapy as a potential treatment avenue for autism spectrum disorder (ASD). It likely covers current strategies, challenges, and future directions for targeting the genetic causes underlying ASD, which may include conditions such as White-Sutton syndrome caused by POGZ variants. The full article is openly accessible via Europe PMC.